Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
2 Acute myeloid leukemia 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
3 Acute myeloid leukemia 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
4 Acute myeloid leukemia 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
5 Acute myeloid leukemia 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
6 Central carbon metabolism in cancer 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
7 Central carbon metabolism in cancer 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
8 Central carbon metabolism in cancer 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
9 Central carbon metabolism in cancer 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
10 Central carbon metabolism in cancer 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
11 Hematopoietic cell lineage 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
12 Hematopoietic cell lineage 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
13 Hematopoietic cell lineage 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
14 Hematopoietic cell lineage 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
15 Hematopoietic cell lineage 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
16 MAPK signaling pathway 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
17 MAPK signaling pathway 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
18 MAPK signaling pathway 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
19 MAPK signaling pathway 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
20 MAPK signaling pathway 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
21 Pathways in cancer 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
22 Pathways in cancer 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
23 Pathways in cancer 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
24 Pathways in cancer 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
25 Pathways in cancer 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
26 PI3K-Akt signaling pathway 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
27 PI3K-Akt signaling pathway 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
28 PI3K-Akt signaling pathway 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
29 PI3K-Akt signaling pathway 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
30 PI3K-Akt signaling pathway 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
31 Ras signaling pathway 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
32 Ras signaling pathway 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
33 Ras signaling pathway 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
34 Ras signaling pathway 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
35 Ras signaling pathway 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
36 Transcriptional misregulation in cancer 💬
 [1] FLT3 💬 Pacritinib 💬 Pacritinib [1] 331 💬
37 Transcriptional misregulation in cancer 💬
 [1] FLT3 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
38 Transcriptional misregulation in cancer 💬
 [1] FLT3 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
39 Transcriptional misregulation in cancer 💬
 [1] FLT3 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
40 Transcriptional misregulation in cancer 💬
 [1] FLT3 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬

Back to top